“Understanding Observational Studies in the time of COVID-19.” New DSRU-FPM joint webinar series
Posted on: Wednesday 14 April 2021
Pharmacoepidemiology is a key discipline for understanding the safety of medicines, which has made important contributions to our understanding of drug safety. It is also being increasingly recognised as a practical tool for supporting risk management and planning safety activities at the time medicines are authorised. Expertise in pharmacoepidemiology is now a must for any research-based pharmaceutical company.
This series of webinars is aimed at introducing you to the basic concepts of pharmacoepidemiology, with some topical COVID-19 examples.
A joint FPM and DSRU Education Event Collaboration – Supporting Pharmaceutical Medicine Physicians and Scientists
Schedule
- Tuesday 4th May | 16:30-17:15
Principles of pharmacoepidemiology
Introduction to this series by Dr Craig Hartford, FPM
Speakers: Prof Saad Shakir and Dr Vicki Osborne, Drug Safety Research Unit
- Tuesday 11th May | 16:30-17:15
Data sources in pharmacoepidemiology (including disease / drug registries)
Introduction by Dr Craig Hartford, FPM
Speakers: Mrs Lorna Hazell and Dr Vicki Osborne, Drug Safety Research Unit
- Tuesday 18th May | 16:30-17:15
Study methods
Introduction by Dr Sheuli Porkiss, FFPM
Speakers: Prof Saad Shakir and Dr Debabrata Roy, Drug Safety Research Unit
- Tuesday 25th May | 16:30-17:15
Data analytics / estimates / definitions
Introduction by Prof. Tim Higenbottam, FPM President
Speakers: Dr Debabrata Roy and Dr Vicki Osborne, Drug Safety Research Unit